North America
Abbott, Mylan silent on why changing tax-inversion terms
Drugmakers Abbott Laboratories (ABT.N) and Mylan Inc (MYL.O) on Wednesday declined to explain in detail why they changed the terms of a $5.3 billion deal in which Mylan will buy part of Abbott's overseas generics business and reincorporate for tax purposes in the Netherlands.
Boeing books first sales to Iran since 1979
Boeing said on Wednesday it had sold aircraft-related goods to Iran Air in the third quarter, marking the first acknowledged dealings between U.S. aerospace companies and Iran since the 1979 U.S. hostage crisis.
Advent, Avista near deal for UCB's Kremers Urban
A consortium of buyout firms Advent International Corp and Avista Capital Partners is in advanced talks to acquire UCB SA's (UCB.BR) U.S. generic drugs unit Kremers Urban Pharmaceuticals Inc, according to people familiar with the matter.
FCC pauses clock on AT&T-DirecTV, Comcast-TWC merger reviews
The U.S. Federal Communications Commission on Wednesday paused its informal "shot clock" deadline on the reviews of the proposed mergers of AT&T Inc (T.N) and DirecTV (DTV.O) and of Comcast Corp (CMCSA.O) and Time Warner Cable Inc (TWC.N) over the issue of confidential programming agreements.